Replies to post #13526 on GTC Biotherapeutics (fka GTCB)

[DewDiligence]

>i) would be great. iii) would be nice if over $1.5 per share.<

So far, so good.

>As for ii) I doubt that GTCB would do a financing currently at these pitiful prices. They do not need it that bad and they can always go to LFB for an additional "loan" if need be.<

How do you arrive at the statement that GTC does not “need it that bad”? Without a new source of capital, the cash will be exhausted in November.

Your assertion that GTC “can always go to LFB for an additional ‘loan’ if need be” sounds naïve. LFB has already spoken on this matter through its actions: a $3M infusion in 2Q08 and another $3M in the second half of the year (which is already in GTC’s cash-burn guidance).

The specificity of LFB’s funding commitment suggests that LFB does not want to be treated as a banker and has drawn the line on the degree to which it will help GTC solve its liquidity problem.


“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”